Results 211 to 220 of about 11,818,839 (321)

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Quantifying intergenerational differences in community public space perception: a multimodal Electroencephalography-eye tracking study. [PDF]

PeerJ
Shang W, Lu D.
europepmc   +1 more source

Sensory processing of learners in the Western Cape diagnosed with attention-deficit/hyperactivity disorder

, 2011
Ray Anne Cook
openalex   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Morphology-guided attention networks for explainable skin cancer detection under clinical uncertainty. [PDF]

Front Oncol
Sajid MZ, Hamid MF, Yang Z, Alhefdi M, Alsenan S, Nam Y.   +5 more
europepmc   +1 more source

Contrastive Learning Enhanced Multi-Level Interest-Aware for Session-Based Recommendation Via Graph Attention Networks

Fan Yang, Dunlu Peng, Yiming Xu, Nan Chen   +3 more
openalex   +1 more source

Additional file 2: of A few of my favorite things: circumscribed interests in autism are not accompanied by increased attentional salience on a personalized selective attention task

, 2017
Owen Parsons, Andrew P. Bayliss, Anna Remington   +2 more
openalex   +1 more source

Checkpoint blockade and the stem‐like T cell trade‐off

Molecular Oncology, EarlyView.
Stem‐like T cells are key to the success of programmed cell death protein 1 (PD1) blockade, as they sustain long‐term anti‐tumor response by continuously generating effector CD8+ T cells. However, how these cells are maintained in cancer is not fully understood. Hor et al.
Julie M. Mazet, Johanna A. Joyce
wiley   +1 more source

Mapping digital popularity: Analyzing the network attention patterns of national forest parks based on Douyin (Tiktok) data. [PDF]

PLoS One
Zhang S, Gu Q.
europepmc   +1 more source